HEADER HYDROLASE 11-APR-08 3CT9 TITLE CRYSTAL STRUCTURE OF A PUTATIVE ZINC PEPTIDASE (NP_812461.1) FROM TITLE 2 BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.31 A RESOLUTION COMPND MOL_ID: 1; COMPND 2 MOLECULE: ACETYLORNITHINE DEACETYLASE; COMPND 3 CHAIN: A, B; COMPND 4 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: BACTEROIDES THETAIOTAOMICRON VPI-5482; SOURCE 3 ORGANISM_TAXID: 226186; SOURCE 4 STRAIN: VPI-5482 / DSM 2079 / NCTC 10582 / E50; SOURCE 5 ATCC: 29148; SOURCE 6 GENE: NP_812461.1, BT_3549; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: HK100; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: SPEEDET KEYWDS NP_812461.1, A PUTATIVE ZINC PEPTIDASE, PEPTIDASE FAMILY M20/M25/M40, KEYWDS 2 STRUCTURAL GENOMICS, JOINT CENTER FOR STRUCTURAL GENOMICS, JCSG, KEYWDS 3 PROTEIN STRUCTURE INITIATIVE, PSI-2, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) REVDAT 6 01-FEB-23 3CT9 1 REMARK SEQADV REVDAT 5 24-JUL-19 3CT9 1 REMARK LINK REVDAT 4 25-OCT-17 3CT9 1 REMARK REVDAT 3 13-JUL-11 3CT9 1 VERSN REVDAT 2 24-FEB-09 3CT9 1 VERSN REVDAT 1 06-MAY-08 3CT9 0 JRNL AUTH JOINT CENTER FOR STRUCTURAL GENOMICS (JCSG) JRNL TITL CRYSTAL STRUCTURE OF A PUTATIVE ZINC PEPTIDASE (NP_812461.1) JRNL TITL 2 FROM BACTEROIDES THETAIOTAOMICRON VPI-5482 AT 2.31 A JRNL TITL 3 RESOLUTION JRNL REF TO BE PUBLISHED JRNL REFN REMARK 2 REMARK 2 RESOLUTION. 2.31 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD WITH PHASES REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.31 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.51 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 98.4 REMARK 3 NUMBER OF REFLECTIONS : 31794 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.197 REMARK 3 R VALUE (WORKING SET) : 0.194 REMARK 3 FREE R VALUE : 0.253 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1613 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.31 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.37 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1810 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 80.93 REMARK 3 BIN R VALUE (WORKING SET) : 0.2180 REMARK 3 BIN FREE R VALUE SET COUNT : 95 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 5230 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 192 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : 39.31 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 29.05 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.27000 REMARK 3 B22 (A**2) : 0.31000 REMARK 3 B33 (A**2) : 1.07000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.79000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.373 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.255 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.192 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 14.210 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.907 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 5363 ; 0.016 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 3610 ; 0.001 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 7266 ; 1.732 ; 1.979 REMARK 3 BOND ANGLES OTHERS (DEGREES): 8847 ; 1.030 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 694 ; 3.898 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 216 ;34.636 ;24.491 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 895 ;13.105 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 30 ;15.622 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 837 ; 0.107 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 5979 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1015 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 926 ; 0.202 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 3457 ; 0.187 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2488 ; 0.168 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): 2636 ; 0.088 ; 0.200 REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 168 ; 0.185 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 9 ; 0.300 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): 19 ; 0.258 ; 0.200 REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 2 ; 0.198 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 3513 ; 0.960 ; 2.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1397 ; 0.229 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5570 ; 1.448 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 2018 ; 1.030 ; 2.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1694 ; 1.511 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : 1 REMARK 3 REMARK 3 NCS GROUP NUMBER : 1 REMARK 3 CHAIN NAMES : A B REMARK 3 NUMBER OF COMPONENTS NCS GROUP : 3 REMARK 3 COMPONENT C SSSEQI TO C SSSEQI CODE REMARK 3 1 A 3 A 174 5 REMARK 3 1 B 3 B 174 5 REMARK 3 2 A 175 A 279 6 REMARK 3 2 B 175 B 279 6 REMARK 3 3 A 280 A 355 5 REMARK 3 3 B 280 B 355 5 REMARK 3 GROUP CHAIN COUNT RMS WEIGHT REMARK 3 MEDIUM POSITIONAL 1 A (A): 1394 ; 0.210 ; 0.500 REMARK 3 LOOSE POSITIONAL 1 A (A): 2861 ; 1.660 ; 5.000 REMARK 3 MEDIUM THERMAL 1 A (A**2): 1394 ; 0.660 ; 2.000 REMARK 3 LOOSE THERMAL 1 A (A**2): 2861 ; 1.520 ;10.000 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 3 A 174 REMARK 3 RESIDUE RANGE : A 280 A 355 REMARK 3 ORIGIN FOR THE GROUP (A): -13.2202 -76.1543 -1.9235 REMARK 3 T TENSOR REMARK 3 T11: -0.0908 T22: -0.0429 REMARK 3 T33: -0.0694 T12: -0.0039 REMARK 3 T13: 0.0239 T23: -0.0248 REMARK 3 L TENSOR REMARK 3 L11: 2.8633 L22: 2.0311 REMARK 3 L33: 3.1322 L12: -0.3345 REMARK 3 L13: -1.1100 L23: -0.0917 REMARK 3 S TENSOR REMARK 3 S11: 0.0210 S12: -0.5692 S13: 0.0973 REMARK 3 S21: 0.3310 S22: 0.0379 S23: 0.0749 REMARK 3 S31: -0.0243 S32: 0.2077 S33: -0.0589 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 175 A 279 REMARK 3 ORIGIN FOR THE GROUP (A): 7.0414 -84.3704 -31.3715 REMARK 3 T TENSOR REMARK 3 T11: -0.1943 T22: -0.1667 REMARK 3 T33: -0.1570 T12: 0.0127 REMARK 3 T13: -0.0495 T23: -0.0046 REMARK 3 L TENSOR REMARK 3 L11: 6.0839 L22: 0.8981 REMARK 3 L33: 1.2680 L12: -1.8357 REMARK 3 L13: -1.5118 L23: 0.2778 REMARK 3 S TENSOR REMARK 3 S11: 0.0842 S12: 0.3350 S13: -0.1436 REMARK 3 S21: -0.0047 S22: -0.0619 S23: 0.0535 REMARK 3 S31: 0.0610 S32: -0.0811 S33: -0.0223 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 2 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 3 B 174 REMARK 3 RESIDUE RANGE : B 280 B 355 REMARK 3 ORIGIN FOR THE GROUP (A): 46.1151-114.3012 -42.8937 REMARK 3 T TENSOR REMARK 3 T11: 0.1297 T22: -0.0556 REMARK 3 T33: -0.0682 T12: 0.1023 REMARK 3 T13: -0.0142 T23: -0.0376 REMARK 3 L TENSOR REMARK 3 L11: 1.5237 L22: 4.4406 REMARK 3 L33: 3.1184 L12: -0.4184 REMARK 3 L13: -0.9060 L23: 1.2232 REMARK 3 S TENSOR REMARK 3 S11: -0.2545 S12: -0.0772 S13: -0.2055 REMARK 3 S21: 0.4702 S22: 0.2613 S23: -0.0357 REMARK 3 S31: 0.7857 S32: 0.2282 S33: -0.0068 REMARK 3 REMARK 3 TLS GROUP : 4 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : B 175 B 279 REMARK 3 ORIGIN FOR THE GROUP (A): 29.2953 -84.3111 -33.9818 REMARK 3 T TENSOR REMARK 3 T11: -0.1888 T22: -0.1641 REMARK 3 T33: -0.1264 T12: 0.0234 REMARK 3 T13: -0.0666 T23: -0.0015 REMARK 3 L TENSOR REMARK 3 L11: 4.4359 L22: 1.2335 REMARK 3 L33: 0.9827 L12: -0.9348 REMARK 3 L13: -1.4637 L23: 0.0211 REMARK 3 S TENSOR REMARK 3 S11: 0.1127 S12: 0.0890 S13: 0.3018 REMARK 3 S21: -0.0658 S22: 0.0187 S23: -0.0746 REMARK 3 S31: -0.0184 S32: -0.0053 S33: -0.1314 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. REMARK 3 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. REMARK 3 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE REMARK 3 INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY REMARK 3 OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 REMARK 3 FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET REMARK 3 INCORPORATION. REMARK 3 4. IODIDE IONS WERE MODELED BASED ON THE CRYSTALLIZATION REMARK 3 CONDITIONS AND ANOMALOUS DIFFERENCE FOURIER PEAKS. REMARK 3 5. CHLORIDE, 1,2-ETHANE DIOL AND PEG WERE MODELED BASED REMARK 3 ON CRYSTALLIZATION AND CRYOPROTECTION CONDITIONS. REMARK 3 6. THE CIS PEPTIDE BONDS BETWEEN 104-105 ARE SUPPORTED BY DENSITY. REMARK 3 7. AMINO ACID PRO 87 IN CHAIN B IS A RAMACHANDRAN OUTLIER IN A REMARK 3 REGION REMARK 3 OF ELECTRON DENSITY THAT IS DIFFICULT TO MODEL. REMARK 4 REMARK 4 3CT9 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-APR-08. REMARK 100 THE DEPOSITION ID IS D_1000047183. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 21-JUN-07 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL11-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97910 REMARK 200 MONOCHROMATOR : SINGLE CRYSTAL SI(111) BENT REMARK 200 (HORIZONTAL FOCUSING) REMARK 200 OPTICS : FLAT MIRROR (VERTICAL FOCUSING) REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 325 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 31807 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.280 REMARK 200 RESOLUTION RANGE LOW (A) : 28.513 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 93.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.04300 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.2300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.28 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.36 REMARK 200 COMPLETENESS FOR SHELL (%) : 42.6 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.24000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 3.000 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: SAD REMARK 200 SOFTWARE USED: SOLVE REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 47.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.33 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: NANODROP, 0.2M NH4I, 20.0% PEG 3350, REMARK 280 NO BUFFER PH 6.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 33.62500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT REMARK 300 WHICH CONSISTS OF 2 CHAINS WHICH FORM A DIMER BASED ON CRYSTAL REMARK 300 PACKING ANALYSIS. SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE REMARK 300 ASSIGNMENT OF A DIMER AS THE SIGNIFICANT OLIGOMERIZATION STATE. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 2770 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 29470 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -14.3 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 0 REMARK 465 MSE A 1 REMARK 465 LYS A 2 REMARK 465 ASN A 81 REMARK 465 GLY A 82 REMARK 465 TRP A 83 REMARK 465 ARG A 84 REMARK 465 LYS A 85 REMARK 465 ASP A 86 REMARK 465 PRO A 87 REMARK 465 GLY B 0 REMARK 465 MSE B 1 REMARK 465 LYS B 2 REMARK 465 LEU B 63 REMARK 465 LYS B 64 REMARK 465 ASN B 81 REMARK 465 GLY B 82 REMARK 465 TRP B 83 REMARK 465 ARG B 84 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 17 CD CE NZ REMARK 470 LYS A 78 CE NZ REMARK 470 GLU A 93 CG CD OE1 OE2 REMARK 470 TYR A 98 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 TYR A 98 OH REMARK 470 GLN A 118 CG CD OE1 NE2 REMARK 470 ASN A 125 CG OD1 ND2 REMARK 470 LYS A 141 NZ REMARK 470 LYS A 184 CE NZ REMARK 470 LYS A 223 NZ REMARK 470 LYS A 292 CD CE NZ REMARK 470 ALA A 330 CB REMARK 470 LYS A 337 CD CE NZ REMARK 470 GLU A 340 CG CD OE1 OE2 REMARK 470 LYS A 354 CG CD CE NZ REMARK 470 GLU B 11 CD OE1 OE2 REMARK 470 LYS B 17 CG CD CE NZ REMARK 470 GLU B 28 CD OE1 OE2 REMARK 470 GLU B 29 OE1 OE2 REMARK 470 GLN B 31 CD OE1 NE2 REMARK 470 PHE B 35 CG CD1 CD2 CE1 CE2 CZ REMARK 470 LEU B 36 CG CD1 CD2 REMARK 470 ASN B 38 CG OD1 ND2 REMARK 470 LEU B 57 CD1 CD2 REMARK 470 MSE B 60 CG SE CE REMARK 470 PHE B 61 CB CG CD1 CD2 CE1 CE2 CZ REMARK 470 ASP B 62 CG OD1 OD2 REMARK 470 LYS B 78 NZ REMARK 470 LYS B 85 CB CG CD CE NZ REMARK 470 ASP B 86 CB CG OD1 OD2 REMARK 470 THR B 89 CB OG1 CG2 REMARK 470 GLU B 93 CG CD OE1 OE2 REMARK 470 ASN B 94 CG OD1 ND2 REMARK 470 LYS B 96 CE NZ REMARK 470 LYS B 141 CG CD CE NZ REMARK 470 LYS B 214 CE NZ REMARK 470 GLU B 285 OE1 OE2 REMARK 470 LYS B 286 CE NZ REMARK 470 LYS B 292 CE NZ REMARK 470 LYS B 295 CG CD CE NZ REMARK 470 LYS B 337 CD CE NZ REMARK 470 LYS B 354 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD1 ASN A 230 OD1 ASN B 230 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 249 NE - CZ - NH1 ANGL. DEV. = 3.5 DEGREES REMARK 500 ARG A 277 NE - CZ - NH2 ANGL. DEV. = -3.3 DEGREES REMARK 500 ARG A 298 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ASP B 240 CB - CA - C ANGL. DEV. = -12.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 27 -4.70 79.73 REMARK 500 ASN A 94 40.95 77.94 REMARK 500 ALA A 105 31.22 -140.43 REMARK 500 SER A 139 50.78 39.74 REMARK 500 THR A 233 -52.01 -135.10 REMARK 500 SER B 24 57.79 -144.03 REMARK 500 ARG B 27 -8.60 80.57 REMARK 500 CYS B 56 115.75 -160.28 REMARK 500 PRO B 87 -104.08 -79.18 REMARK 500 THR B 233 -62.39 -134.41 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD B 356 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 357 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD A 358 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE IOD B 359 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 363 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 362 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 364 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 365 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO A 363 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE EDO B 366 REMARK 800 REMARK 800 SITE_IDENTIFIER: BC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PEG B 367 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 375081 RELATED DB: TARGETDB REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG REMARK 999 MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE REMARK 999 LEAVING ONLY A GLYCINE FOLLOWED BY THE TARGET SEQUENCE. DBREF 3CT9 A 1 355 UNP Q8A1V9 Q8A1V9_BACTN 1 355 DBREF 3CT9 B 1 355 UNP Q8A1V9 Q8A1V9_BACTN 1 355 SEQADV 3CT9 GLY A 0 UNP Q8A1V9 EXPRESSION TAG SEQADV 3CT9 GLY B 0 UNP Q8A1V9 EXPRESSION TAG SEQRES 1 A 356 GLY MSE LYS TYR ASP ILE PRO THR MSE THR ALA GLU ALA SEQRES 2 A 356 VAL SER LEU LEU LYS SER LEU ILE SER ILE PRO SER ILE SEQRES 3 A 356 SER ARG GLU GLU THR GLN ALA ALA ASP PHE LEU GLN ASN SEQRES 4 A 356 TYR ILE GLU ALA GLU GLY MSE GLN THR GLY ARG LYS GLY SEQRES 5 A 356 ASN ASN VAL TRP CYS LEU SER PRO MSE PHE ASP LEU LYS SEQRES 6 A 356 LYS PRO THR ILE LEU LEU ASN SER HIS ILE ASP THR VAL SEQRES 7 A 356 LYS PRO VAL ASN GLY TRP ARG LYS ASP PRO PHE THR PRO SEQRES 8 A 356 ARG GLU GLU ASN GLY LYS LEU TYR GLY LEU GLY SER ASN SEQRES 9 A 356 ASP ALA GLY ALA SER VAL VAL SER LEU LEU GLN VAL PHE SEQRES 10 A 356 LEU GLN LEU CYS ARG THR SER GLN ASN TYR ASN LEU ILE SEQRES 11 A 356 TYR LEU ALA SER CYS GLU GLU GLU VAL SER GLY LYS GLU SEQRES 12 A 356 GLY ILE GLU SER VAL LEU PRO GLY LEU PRO PRO VAL SER SEQRES 13 A 356 PHE ALA ILE VAL GLY GLU PRO THR GLU MSE GLN PRO ALA SEQRES 14 A 356 ILE ALA GLU LYS GLY LEU MSE VAL LEU ASP VAL THR ALA SEQRES 15 A 356 THR GLY LYS ALA GLY HIS ALA ALA ARG ASP GLU GLY ASP SEQRES 16 A 356 ASN ALA ILE TYR LYS VAL LEU ASN ASP ILE ALA TRP PHE SEQRES 17 A 356 ARG ASP TYR ARG PHE GLU LYS GLU SER PRO LEU LEU GLY SEQRES 18 A 356 PRO VAL LYS MSE SER VAL THR VAL ILE ASN ALA GLY THR SEQRES 19 A 356 GLN HIS ASN VAL VAL PRO ASP LYS CYS THR PHE VAL VAL SEQRES 20 A 356 ASP ILE ARG SER ASN GLU LEU TYR SER ASN GLU ASP LEU SEQRES 21 A 356 PHE ALA GLU ILE ARG LYS HIS ILE ALA CYS ASP ALA LYS SEQRES 22 A 356 ALA ARG SER PHE ARG LEU ASN SER SER ARG ILE ASP GLU SEQRES 23 A 356 LYS HIS PRO PHE VAL GLN LYS ALA VAL LYS MSE GLY ARG SEQRES 24 A 356 ILE PRO PHE GLY SER PRO THR LEU SER ASP GLN ALA LEU SEQRES 25 A 356 MSE SER PHE ALA SER VAL LYS ILE GLY PRO GLY ARG SER SEQRES 26 A 356 SER ARG SER HIS THR ALA GLU GLU TYR ILE MSE LEU LYS SEQRES 27 A 356 GLU ILE GLU GLU ALA ILE GLY ILE TYR LEU ASP LEU LEU SEQRES 28 A 356 ASP GLY LEU LYS LEU SEQRES 1 B 356 GLY MSE LYS TYR ASP ILE PRO THR MSE THR ALA GLU ALA SEQRES 2 B 356 VAL SER LEU LEU LYS SER LEU ILE SER ILE PRO SER ILE SEQRES 3 B 356 SER ARG GLU GLU THR GLN ALA ALA ASP PHE LEU GLN ASN SEQRES 4 B 356 TYR ILE GLU ALA GLU GLY MSE GLN THR GLY ARG LYS GLY SEQRES 5 B 356 ASN ASN VAL TRP CYS LEU SER PRO MSE PHE ASP LEU LYS SEQRES 6 B 356 LYS PRO THR ILE LEU LEU ASN SER HIS ILE ASP THR VAL SEQRES 7 B 356 LYS PRO VAL ASN GLY TRP ARG LYS ASP PRO PHE THR PRO SEQRES 8 B 356 ARG GLU GLU ASN GLY LYS LEU TYR GLY LEU GLY SER ASN SEQRES 9 B 356 ASP ALA GLY ALA SER VAL VAL SER LEU LEU GLN VAL PHE SEQRES 10 B 356 LEU GLN LEU CYS ARG THR SER GLN ASN TYR ASN LEU ILE SEQRES 11 B 356 TYR LEU ALA SER CYS GLU GLU GLU VAL SER GLY LYS GLU SEQRES 12 B 356 GLY ILE GLU SER VAL LEU PRO GLY LEU PRO PRO VAL SER SEQRES 13 B 356 PHE ALA ILE VAL GLY GLU PRO THR GLU MSE GLN PRO ALA SEQRES 14 B 356 ILE ALA GLU LYS GLY LEU MSE VAL LEU ASP VAL THR ALA SEQRES 15 B 356 THR GLY LYS ALA GLY HIS ALA ALA ARG ASP GLU GLY ASP SEQRES 16 B 356 ASN ALA ILE TYR LYS VAL LEU ASN ASP ILE ALA TRP PHE SEQRES 17 B 356 ARG ASP TYR ARG PHE GLU LYS GLU SER PRO LEU LEU GLY SEQRES 18 B 356 PRO VAL LYS MSE SER VAL THR VAL ILE ASN ALA GLY THR SEQRES 19 B 356 GLN HIS ASN VAL VAL PRO ASP LYS CYS THR PHE VAL VAL SEQRES 20 B 356 ASP ILE ARG SER ASN GLU LEU TYR SER ASN GLU ASP LEU SEQRES 21 B 356 PHE ALA GLU ILE ARG LYS HIS ILE ALA CYS ASP ALA LYS SEQRES 22 B 356 ALA ARG SER PHE ARG LEU ASN SER SER ARG ILE ASP GLU SEQRES 23 B 356 LYS HIS PRO PHE VAL GLN LYS ALA VAL LYS MSE GLY ARG SEQRES 24 B 356 ILE PRO PHE GLY SER PRO THR LEU SER ASP GLN ALA LEU SEQRES 25 B 356 MSE SER PHE ALA SER VAL LYS ILE GLY PRO GLY ARG SER SEQRES 26 B 356 SER ARG SER HIS THR ALA GLU GLU TYR ILE MSE LEU LYS SEQRES 27 B 356 GLU ILE GLU GLU ALA ILE GLY ILE TYR LEU ASP LEU LEU SEQRES 28 B 356 ASP GLY LEU LYS LEU MODRES 3CT9 MSE A 8 MET SELENOMETHIONINE MODRES 3CT9 MSE A 45 MET SELENOMETHIONINE MODRES 3CT9 MSE A 60 MET SELENOMETHIONINE MODRES 3CT9 MSE A 165 MET SELENOMETHIONINE MODRES 3CT9 MSE A 175 MET SELENOMETHIONINE MODRES 3CT9 MSE A 224 MET SELENOMETHIONINE MODRES 3CT9 MSE A 296 MET SELENOMETHIONINE MODRES 3CT9 MSE A 312 MET SELENOMETHIONINE MODRES 3CT9 MSE A 335 MET SELENOMETHIONINE MODRES 3CT9 MSE B 8 MET SELENOMETHIONINE MODRES 3CT9 MSE B 45 MET SELENOMETHIONINE MODRES 3CT9 MSE B 60 MET SELENOMETHIONINE MODRES 3CT9 MSE B 165 MET SELENOMETHIONINE MODRES 3CT9 MSE B 175 MET SELENOMETHIONINE MODRES 3CT9 MSE B 224 MET SELENOMETHIONINE MODRES 3CT9 MSE B 296 MET SELENOMETHIONINE MODRES 3CT9 MSE B 312 MET SELENOMETHIONINE MODRES 3CT9 MSE B 335 MET SELENOMETHIONINE HET MSE A 8 8 HET MSE A 45 8 HET MSE A 60 8 HET MSE A 165 8 HET MSE A 175 8 HET MSE A 224 8 HET MSE A 296 8 HET MSE A 312 8 HET MSE A 335 8 HET MSE B 8 8 HET MSE B 45 8 HET MSE B 60 5 HET MSE B 165 8 HET MSE B 175 8 HET MSE B 224 8 HET MSE B 296 8 HET MSE B 312 8 HET MSE B 335 8 HET IOD A 356 1 HET IOD A 357 1 HET IOD A 358 1 HET CL A 359 1 HET CL A 360 1 HET CL A 361 1 HET EDO A 362 4 HET EDO A 363 4 HET IOD B 356 1 HET IOD B 357 1 HET IOD B 358 1 HET IOD B 359 1 HET IOD B 360 1 HET CL B 361 1 HET CL B 362 1 HET CL B 363 1 HET EDO B 364 4 HET EDO B 365 4 HET EDO B 366 4 HET PEG B 367 7 HETNAM MSE SELENOMETHIONINE HETNAM IOD IODIDE ION HETNAM CL CHLORIDE ION HETNAM EDO 1,2-ETHANEDIOL HETNAM PEG DI(HYDROXYETHYL)ETHER HETSYN EDO ETHYLENE GLYCOL FORMUL 1 MSE 18(C5 H11 N O2 SE) FORMUL 3 IOD 8(I 1-) FORMUL 6 CL 6(CL 1-) FORMUL 9 EDO 5(C2 H6 O2) FORMUL 22 PEG C4 H10 O3 FORMUL 23 HOH *192(H2 O) HELIX 1 1 ASP A 4 SER A 21 1 18 HELIX 2 2 GLU A 29 GLU A 43 1 15 HELIX 3 3 ALA A 105 CYS A 120 1 16 HELIX 4 4 GLU A 135 SER A 139 5 5 HELIX 5 5 GLY A 143 LEU A 148 1 6 HELIX 6 6 PRO A 149 LEU A 151 5 3 HELIX 7 7 ILE A 197 LYS A 199 5 3 HELIX 8 8 VAL A 200 TYR A 210 1 11 HELIX 9 9 SER A 255 ILE A 267 1 13 HELIX 10 10 HIS A 287 MSE A 296 1 10 HELIX 11 11 SER A 307 MSE A 312 5 6 HELIX 12 12 ARG A 323 SER A 327 5 5 HELIX 13 13 LEU A 336 ASP A 351 1 16 HELIX 14 14 ASP B 4 ILE B 22 1 19 HELIX 15 15 GLU B 29 ALA B 42 1 14 HELIX 16 16 ALA B 105 CYS B 120 1 16 HELIX 17 17 GLY B 143 VAL B 147 5 5 HELIX 18 18 ILE B 197 LYS B 199 5 3 HELIX 19 19 VAL B 200 TYR B 210 1 11 HELIX 20 20 SER B 255 LYS B 265 1 11 HELIX 21 21 HIS B 287 MSE B 296 1 10 HELIX 22 22 SER B 307 MSE B 312 5 6 HELIX 23 23 ARG B 323 SER B 327 5 5 HELIX 24 24 LEU B 336 ASP B 351 1 16 SHEET 1 A 6 THR A 47 LYS A 50 0 SHEET 2 A 6 ASN A 53 LEU A 57 -1 O TRP A 55 N GLY A 48 SHEET 3 A 6 ASN A 127 SER A 133 -1 O ALA A 132 N VAL A 54 SHEET 4 A 6 THR A 67 HIS A 73 1 N LEU A 70 O ILE A 129 SHEET 5 A 6 PHE A 156 VAL A 159 1 O ILE A 158 N LEU A 69 SHEET 6 A 6 SER A 316 LYS A 318 1 O VAL A 317 N VAL A 159 SHEET 1 B 3 ARG A 91 GLU A 92 0 SHEET 2 B 3 LYS A 96 TYR A 98 -1 O TYR A 98 N ARG A 91 SHEET 3 B 3 TYR A 333 MSE A 335 -1 O ILE A 334 N LEU A 97 SHEET 1 C 3 SER A 281 ARG A 282 0 SHEET 2 C 3 ALA A 168 GLU A 171 -1 N GLU A 171 O SER A 281 SHEET 3 C 3 PHE A 301 SER A 303 1 O SER A 303 N ALA A 170 SHEET 1 D 8 ASP A 270 ALA A 273 0 SHEET 2 D 8 MSE A 175 THR A 182 -1 N THR A 180 O ASP A 270 SHEET 3 D 8 LYS A 241 ARG A 249 -1 O CYS A 242 N ALA A 181 SHEET 4 D 8 LYS A 223 ALA A 231 -1 N LYS A 223 O ARG A 249 SHEET 5 D 8 LYS B 223 ALA B 231 -1 O ALA B 231 N ILE A 229 SHEET 6 D 8 LYS B 241 ARG B 249 -1 O ARG B 249 N LYS B 223 SHEET 7 D 8 MSE B 175 THR B 182 -1 N ALA B 181 O CYS B 242 SHEET 8 D 8 ASP B 270 ALA B 273 -1 O LYS B 272 N ASP B 178 SHEET 1 E 6 GLY B 48 LYS B 50 0 SHEET 2 E 6 ASN B 53 LEU B 57 -1 O TRP B 55 N GLY B 48 SHEET 3 E 6 ASN B 127 SER B 133 -1 O ALA B 132 N VAL B 54 SHEET 4 E 6 THR B 67 HIS B 73 1 N LEU B 70 O ILE B 129 SHEET 5 E 6 PHE B 156 VAL B 159 1 O ILE B 158 N LEU B 69 SHEET 6 E 6 ALA B 315 LYS B 318 1 O VAL B 317 N VAL B 159 SHEET 1 F 3 ARG B 91 GLU B 93 0 SHEET 2 F 3 LYS B 96 TYR B 98 -1 O TYR B 98 N ARG B 91 SHEET 3 F 3 TYR B 333 MSE B 335 -1 O ILE B 334 N LEU B 97 SHEET 1 G 3 SER B 281 ARG B 282 0 SHEET 2 G 3 ALA B 168 GLU B 171 -1 N GLU B 171 O SER B 281 SHEET 3 G 3 PHE B 301 SER B 303 1 O SER B 303 N ALA B 170 LINK C THR A 7 N MSE A 8 1555 1555 1.33 LINK C MSE A 8 N THR A 9 1555 1555 1.33 LINK C GLY A 44 N MSE A 45 1555 1555 1.33 LINK C MSE A 45 N GLN A 46 1555 1555 1.33 LINK C PRO A 59 N MSE A 60 1555 1555 1.33 LINK C MSE A 60 N PHE A 61 1555 1555 1.31 LINK C GLU A 164 N MSE A 165 1555 1555 1.33 LINK C MSE A 165 N GLN A 166 1555 1555 1.34 LINK C LEU A 174 N MSE A 175 1555 1555 1.34 LINK C MSE A 175 N VAL A 176 1555 1555 1.34 LINK C LYS A 223 N MSE A 224 1555 1555 1.34 LINK C MSE A 224 N SER A 225 1555 1555 1.34 LINK C LYS A 295 N MSE A 296 1555 1555 1.33 LINK C MSE A 296 N GLY A 297 1555 1555 1.33 LINK C LEU A 311 N MSE A 312 1555 1555 1.33 LINK C MSE A 312 N SER A 313 1555 1555 1.32 LINK C ILE A 334 N MSE A 335 1555 1555 1.33 LINK C MSE A 335 N LEU A 336 1555 1555 1.33 LINK C THR B 7 N MSE B 8 1555 1555 1.33 LINK C MSE B 8 N THR B 9 1555 1555 1.34 LINK C GLY B 44 N MSE B 45 1555 1555 1.34 LINK C MSE B 45 N GLN B 46 1555 1555 1.33 LINK C PRO B 59 N MSE B 60 1555 1555 1.34 LINK C MSE B 60 N PHE B 61 1555 1555 1.33 LINK C GLU B 164 N MSE B 165 1555 1555 1.33 LINK C MSE B 165 N GLN B 166 1555 1555 1.33 LINK C LEU B 174 N MSE B 175 1555 1555 1.33 LINK C MSE B 175 N VAL B 176 1555 1555 1.34 LINK C LYS B 223 N MSE B 224 1555 1555 1.33 LINK C MSE B 224 N SER B 225 1555 1555 1.33 LINK C LYS B 295 N MSE B 296 1555 1555 1.33 LINK C MSE B 296 N GLY B 297 1555 1555 1.33 LINK C LEU B 311 N MSE B 312 1555 1555 1.33 LINK C MSE B 312 N SER B 313 1555 1555 1.33 LINK C ILE B 334 N MSE B 335 1555 1555 1.33 LINK C MSE B 335 N LEU B 336 1555 1555 1.33 CISPEP 1 ASP A 104 ALA A 105 0 2.86 CISPEP 2 ASP B 104 ALA B 105 0 -0.55 SITE 1 AC1 2 SER B 303 SER B 324 SITE 1 AC2 2 HIS A 235 ARG B 274 SITE 1 AC3 1 SER A 303 SITE 1 AC4 2 SER B 275 PHE B 276 SITE 1 AC5 3 GLU B 136 SER B 139 SER B 307 SITE 1 AC6 1 SER A 275 SITE 1 AC7 2 GLU A 257 ALA B 273 SITE 1 AC8 3 ASN B 202 ASP B 203 HIS B 266 SITE 1 AC9 4 ARG A 277 ASN A 279 ALA A 310 LEU A 311 SITE 1 BC1 3 SER B 58 CYS B 120 TYR B 126 SITE 1 BC2 4 ARG A 274 THR B 233 GLN B 234 HIS B 235 CRYST1 51.340 67.250 107.890 90.00 94.28 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019478 0.000000 0.001458 0.00000 SCALE2 0.000000 0.014870 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009295 0.00000